Nigeria rolls out new Oxford R21 malaria vaccine

Reuters10-17

By Camillus Eboh

ABUJA, Oct 17 (Reuters) - Nigeria launched a new malaria vaccine on Thursday that will be freely administered to recipients, its health minister said, marking a significant milestone in its fight against the deadly disease.

The launch makes the country one of the first in the world to back the new R21 vaccine, developed by scientists at Oxford University and made by the Serum Institute of India and Novavax.

The vaccine was provisionally approved by Nigeria's medicines regulator in April last year.

Health Minister Muhammad Ali Pate said Nigeria had received 846,200 doses of the vaccine, procured in partnership with global vaccine group Gavi, the Vaccine Alliance and UNICEF. A balance of 153,800 more doses is expected on Oct. 26 to make it a million.

"The Vaccines are not enough, so in the context that they are not enough but free, I want to encourage all well-meaning Nigerians to take advantage of the limited availability and make their wards available to be administered and protected," Pate told reporters at the launch in the capital Abuja.

The roll out will start with two pilot states of Kebbi in the north and Bayelsa on the coast, ahead of a national roll out, Pate said.

Malaria, a mosquito-borne disease, kills more than 600,000 people each year, most of them African babies and children.

Nigeria, Africa's most populous nation, is the world's worst-affected country with 31% of global deaths from malaria, according to a 2023 World Health Organization (WHO) report.

(Reporting by Camillus Eboh; Writing by Elisha Bala-Gbogbo; Editing by Bernadette Baum)

((Elisha.Bala-Gbogbo@thomsonreuters.com; Reuters Messaging: elisha.bala-gbgobo.thomsonreuters.com@reuters.net))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2476143444?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-17 18:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2476143444","market":"us","top_or_hot":-1,"title":"Nigeria rolls out new Oxford R21 malaria vaccine","media":"Reuters","content":"<html><body><p>By Camillus Eboh</p><p>      ABUJA, Oct 17 (Reuters) - Nigeria launched a new malaria vaccine on Thursday that will be freely administered to recipients, its health minister said, marking a significant milestone in its fight against the deadly disease.</p><p>   The launch makes the country one of the first in the world to back the new R21 vaccine, developed by scientists at Oxford University and made by the Serum Institute of India and Novavax.</p><p>   The vaccine was provisionally approved by Nigeria's medicines regulator in April last year. </p><p>   Health Minister Muhammad Ali Pate said Nigeria had received 846,200 doses of the vaccine, procured in partnership with global vaccine group Gavi, the Vaccine Alliance and UNICEF. A balance of 153,800 more doses is expected on Oct. 26 to make it a million.</p><p>   \"The Vaccines are not enough, so in the context that they are not enough but free, I want to encourage all well-meaning Nigerians to take advantage of the limited availability and make their wards available to be administered and protected,\" Pate told reporters at the launch in the capital Abuja.</p><p>   The roll out will start with two pilot states of Kebbi in the north and Bayelsa on the coast, ahead of a national roll out, Pate said. </p><p>   Malaria, a mosquito-borne disease, kills more than 600,000 people each year, most of them African babies and children.</p><p>   Nigeria, Africa's most populous nation, is the world's worst-affected country with 31% of global deaths from malaria, according to a 2023 World Health Organization (WHO) report.</p><p> (Reporting by Camillus Eboh; Writing by Elisha Bala-Gbogbo; Editing by Bernadette Baum)</p><p>((Elisha.Bala-Gbogbo@thomsonreuters.com; Reuters Messaging: elisha.bala-gbgobo.thomsonreuters.com@reuters.net))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nigeria rolls out new Oxford R21 malaria vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNigeria rolls out new Oxford R21 malaria vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-17 18:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Camillus Eboh      ABUJA, Oct 17 (Reuters) - Nigeria launched a new malaria vaccine on Thursday that will be freely administered to recipients, its health minister said, marking a significant ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4202","symbol_name":"服装、服饰与奢侈品","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2476143444","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2476143444","pubTimestamp":1729162537,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"By Camillus Eboh      ABUJA, Oct 17 (Reuters) - Nigeria launched a new malaria vaccine on Thursday that will be freely administered to recipients, its health minister said, marking a significant miles","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4202":"服装、服饰与奢侈品","NVAX":"诺瓦瓦克斯医药","OXM":"牛津工业"},"translate_title":"尼日利亚推出新的牛津R21疟疾疫苗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OXM":1,"NVAX":0.8},"content_text":"By Camillus Eboh      ABUJA, Oct 17 (Reuters) - Nigeria launched a new malaria vaccine on Thursday that will be freely administered to recipients, its health minister said, marking a significant milestone in its fight against the deadly disease.   The launch makes the country one of the first in the world to back the new R21 vaccine, developed by scientists at Oxford University and made by the Serum Institute of India and Novavax.   The vaccine was provisionally approved by Nigeria's medicines regulator in April last year.    Health Minister Muhammad Ali Pate said Nigeria had received 846,200 doses of the vaccine, procured in partnership with global vaccine group Gavi, the Vaccine Alliance and UNICEF. A balance of 153,800 more doses is expected on Oct. 26 to make it a million.   \"The Vaccines are not enough, so in the context that they are not enough but free, I want to encourage all well-meaning Nigerians to take advantage of the limited availability and make their wards available to be administered and protected,\" Pate told reporters at the launch in the capital Abuja.   The roll out will start with two pilot states of Kebbi in the north and Bayelsa on the coast, ahead of a national roll out, Pate said.    Malaria, a mosquito-borne disease, kills more than 600,000 people each year, most of them African babies and children.   Nigeria, Africa's most populous nation, is the world's worst-affected country with 31% of global deaths from malaria, according to a 2023 World Health Organization (WHO) report. (Reporting by Camillus Eboh; Writing by Elisha Bala-Gbogbo; Editing by Bernadette Baum)((Elisha.Bala-Gbogbo@thomsonreuters.com; Reuters Messaging: elisha.bala-gbgobo.thomsonreuters.com@reuters.net))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Product Release","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2476143444"}